Significant Publications on Infectious Diseases Pharmacotherapy in 2016

Fong, Gary; Skoglund, Erik; Phe, Kady; Guastadisegni, Jessica; Shea, Katherine M.; McDaneld, Patrick M.; Perez, Katherine K.; Sofjan, Amelia K.

doi:10.1177/0897190017727212

Cited by 14 publications

(11 citation statements)

References 74 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our cohort, the most common ways respondents maintained awareness of best practices were learner‐focused journal clubs and participation in listserv discussions. Other methods included annotated summaries of journal articles, journal eTOCs, manual literature searches, monthly web‐based journal clubs, and social media . In particular, ID and CC pharmacists read journals in their own specialties rather than another group's specialty, which may partially explain differences in practices and perceptions.…”

Section: Discussionmentioning

confidence: 99%

Perceptions and practices for beta‐lactam antibiotic dosing, administration, and monitoring in critically ill patients: Current views and use among critical care and infectious diseases pharmacists

Hammond

McCreary

Rech

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Purpose To elucidate considerations that infectious diseases (ID) and critical care (CC) pharmacists have regarding beta‐lactam antibiotics in critically ill adult patients in order to identify areas for practice improvement and future research. Materials and Methods A 17‐item survey was distributed to ID and CC pharmacists. Responses were characterized using frequency and descriptive statistics. Categorical variables were compared using χ2 or Fisher's exact test, as appropriate. Results Ninety‐five of 834 ID pharmacists (11.4%) and 221 of 1436 CC pharmacists (15.4%) participated. Compared with ID pharmacists, more CC pharmacists would administer renally‐excreted beta‐lactams in critically ill patients with reduced renal function without dosage adjustment for 24 hours (17% vs 34%, P = 0.002). Most respondents believed therapeutic drug monitoring would be somewhat/very important in all surveyed scenarios. ID pharmacists more frequently believed antimicrobial stewardship teams should conduct prospective audits for definitive beta‐lactam therapy (98% vs 86%, P = 0.001), develop protocols for beta‐lactam use (95% vs 85%, P = 0.019), recommend beta‐lactam dosing (98% vs 85%, P < 0.001), and recommend empirical beta‐lactam selection (95% vs 81%, P = 0.001) compared with CC pharmacists. Conclusion Beta‐lactam dosing and monitoring recommendations in critically ill adults were frequently similar between pharmacy specialties. Research should be conducted in areas where opinions differ between specialties.

show abstract

Section: Discussionmentioning

confidence: 99%

Perceptions and practices for beta‐lactam antibiotic dosing, administration, and monitoring in critically ill patients: Current views and use among critical care and infectious diseases pharmacists

Hammond

McCreary

Rech

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…To help alleviate this task, the Houston Infectious Diseases Network (HIDN) summarizes annually the prior year's most significant ID publications. [1][2][3][4][5][6][7][8][9][10][11][12] HIDN consists of ID clinicians from the Texas Medical Center in Houston, TX, and includes physicians, pharmacists, microbiologists, and researchers from over 15 institutions. The network regularly meets throughout the year to discuss collaborative efforts in best practices, education, research, and stewardship.…”

Section: Introductionmentioning

confidence: 99%

Significant Publications on Infectious Diseases Pharmacotherapy in 2019

Hendrickson

Spitznogle

Gonzales-Luna

et al. 2020

Journal of Pharmacy Practice

Self Cite

View full text Add to dashboard Cite

Purpose To provide a summary of the most prominent peer-reviewed infectious diseases (ID) pharmacotherapy and Human Immunodeficiency Virus (HIV)-related articles published in 2019. Summary Houston Infectious Diseases Network (HIDN) members were asked to nominate articles that they believed were most influential within the ID and HIV pharmacotherapy science communities. A total of 48 general ID and 6 HIV-related articles were nominated. Following nominations, an online survey was distributed via e-mail to Society of Infectious Diseases Pharmacists (SIDP) members, with a total of 156 and 54 members voting for general ID and HIV-related articles, respectively. The results of this survey were ranked to determine the top 10 general ID and top HIV articles. The top articles were then summarized by HIDN members, including residents, fellows, and clinical pharmacists. Conclusion This review covers many of the most influential ID articles published in 2019, including 3 practice guideline updates. Due to the high rate of ID literature published each year, this review continues to help summarize these articles for the ID community, allowing clinicians to remain up-to-date on practice-changing publications in ID and HIV pharmacotherapy.

show abstract

“…Each year since 2009, the HIDN has led efforts to compile and review the top 10 significant publications in ID pharmacotherapy. [1][2][3][4][5][6][7][8][9] The purpose of this annual publication is to provide clinicians with an easily accessible summary of some of the most important developments in the field. Similar to previous years, at the end of 2018, HIDN members were asked to nominate articles thought to have most influenced ID pharmacotherapy practice in 2018, including those related to human immunodeficiency virus (HIV).…”

Section: Introductionmentioning

confidence: 99%

“…A classification and regression tree analysis was performed to identify the fAUC/MIC thresholds most predictive of 30-day survival and microbiological response. After the PD threshold was determined, it was applied in Monte Carlo simulations (5000 female and 5000 male simulations) to determine the probability of target attainment (PTA) of various daptomycin dosing regimens (6,8,10, and 12 mg/kg/d). The fAUC/MIC PTA was calculated for doubling MIC dilutions between 0.25 and 16 mg/L, and an a priori PTA >90% was defined as optimal.…”

Section: Introductionmentioning

confidence: 99%

Significant Publications on Infectious Diseases Pharmacotherapy in 2018

Borjan

Gonzales-Luna

Carlson

et al. 2019

Journal of Pharmacy Practice

Self Cite

View full text Add to dashboard Cite

Purpose: To summarize the top 10 most influential peer-reviewed infectious diseases (ID) pharmacotherapy articles published in the year 2018. Summary: Members of the Houston Infectious Diseases Network (HIDN) nominated articles that were thought to have most notably contributed to ID pharmacotherapy in 2018, including those related to human immunodeficiency virus (HIV). A total of 26 articles were nominated: 22 articles pertaining to general ID pharmacotherapy and 4 articles involving HIV/AIDS. To select the most significant articles of 2018, a survey was created and distributed to members of the Society of Infectious Diseases Pharmacists (SIDP) asking members to vote on their top 10 general ID publications and 1 HIV publication. Of the 462 members surveyed, 213 (46%) and 108 (23%) voted for general ID pharmacotherapy- and HIV-related articles, respectively. The top article(s) for both categories are summarized. Conclusion: With the increased emphasis on antimicrobial stewardship initiatives and the growing problem of multidrug-resistant (MDR) organisms, the amount of ID literature centered on stewardship, appropriate treatment durations, and newly approved antimicrobial agents continues to expand, making it challenging for clinicians to stay informed on the most relevant publications. This review summarizes significant ID-related publications in 2018 with the goal of aiding clinicians in staying up to date on the most noteworthy publications in ID pharmacotherapy.

show abstract

Significant Publications on Infectious Diseases Pharmacotherapy in 2016

Abstract: With the large number of ID-related articles published each year, it can be challenging to stay current with the most relevant ID publications. This review of significant publications in 2016 may provide a starting point for that process.

Cited by 14 publications

References 74 publications

Perceptions and practices for beta‐lactam antibiotic dosing, administration, and monitoring in critically ill patients: Current views and use among critical care and infectious diseases pharmacists

Perceptions and practices for beta‐lactam antibiotic dosing, administration, and monitoring in critically ill patients: Current views and use among critical care and infectious diseases pharmacists

Significant Publications on Infectious Diseases Pharmacotherapy in 2019

Significant Publications on Infectious Diseases Pharmacotherapy in 2018

Contact Info

Product

Resources

About